您可能也喜欢
When Kaiqing isn’t making waves in biotech, you’ll likely find him dominating the basketball court in Germany, where he plays for an amateur club. But his passions don’t stop there. Music has been a huge part of his life too! Back in college, he was the heartbeat of his band as a drummer, keeping the rhythm alive both on and off stage. These days, he’s channeling his energy into fitness, hitting the gym regularly and loving the transformation it brings, both physically and mentally. Whether it’s biotech, basketball, music, or fitness, Kaiqing brings his A-game to everything he does!
Breaking Down Business Development
In many ways, business development licensing is a lot like sports. It’s all about strategy, teamwork, and knowing when to make your move. It starts with building relationships, much like sales, but instead of promoting a product, the goal is to spark conversations around antibody licensing and patent transfers. The next phase is where science takes center stage, showcasing the data, demonstrating a drug’s advantages, and ensuring both sides align on its potential. Then comes the final and often toughest stage: negotiation. Deal structures are crafted, covering upfront payments, milestones, and royalties, with Business Development, legal, and finance teams working together to secure agreements that make sense for everyone involved.
Kaiqing’s journey into this fast-paced world started at Biocytogen’s German site, where he initially had no business experience. He began by supporting the team in a scientific capacity, preparing posters and slides, before gradually stepping into business calls and negotiations across Europe. That hands-on learning curve eventually brought him to the Bay Area, where he became an independent business development manager. One of his proudest achievements was successfully licensing out a bispecific ADC drug last year, as it was the first of its kind for Biocytogen, incorporating their proprietary linker-payload technology.
Endless Learning & Innovation
What keeps Kaiqing hooked on biotech is the constant evolution. With multiple antibody and ADC projects happening at once, every day brings new opportunities to learn and grow. Whether it’s diving into the latest drug mechanisms, strategizing licensing deals, or collaborating with partners across the industry, the dynamic nature of this work keeps things exciting. His scientific background plays a key role, but the ability to connect with people is just as important. Conversations with colleagues, each bringing their own expertise, help him refine his skills, while negotiations with external partners offer fresh perspectives. Biocytogen isn’t just about advancing therapeutics. It’s about continuous learning, pushing boundaries, and working together to bring groundbreaking treatments to life.
Lessons Learned & Advice for the Next Generation
For Kaiqing, no deal is done until the ink dries, and even then, surprises can happen. One of the biggest lessons Kaiqing has learned is to keep a pulse on the industry. Market shifts, acquisitions, and unforeseen developments can change the playing field overnight, so staying ahead of trends and acting swiftly is crucial. Internally, navigating successful negotiations requires tight collaboration across teams, ensuring all perspectives are aligned.
For those looking to break into biotech, Kaiqing’s advice is simple: keep an open mind. This field moves at lightning speed, with new breakthroughs happening daily, especially now as AI transforms drug discovery. Staying adaptable, embracing fresh ideas, and pushing forward even after setbacks will take you far. Above all, don’t give up. Every challenge is a learning opportunity, and persistence is the key to success.
